EP102

· Epics Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EP102, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors [Phase 1]